Apellis Pharmaceuticals - Syfovre® (Pegcetacoplan Injection) Preserved Visual Function at 36 Months in Gale Extension Study in Geographic Atrophy (Ga)
apellis pharmaceuticals - Syfovre®(佩格西他克朋注射液)在地理萎縮(GA)的Gale延續研究中保持了36個月的視覺功能
Apellis Pharmaceuticals - Syfovre® (Pegcetacoplan Injection) Preserved Visual Function at 36 Months in Gale Extension Study in Geographic Atrophy (Ga)
apellis pharmaceuticals - Syfovre®(佩格西他克朋注射液)在地理萎縮(GA)的Gale延續研究中保持了36個月的視覺功能
譯文內容由第三人軟體翻譯。